S. 3711 · 115th Congress
Opioid Treatment Surge Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
No cosponsors.
This bill establishes a retroactive annual fee for opioid manufacturers, based on the manufacturer's share of the opioid drug market.
What it does: CRS summary · Introduced in Senate · Dec 5, 2018
Opioid Treatment Surge Act
This bill establishes a retroactive annual fee for opioid manufacturers, based on the manufacturer's share of the opioid drug market.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Opioid Treatment Surge Act
Latest action (Dec 5, 2018): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Dec 5, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.